local_hospital

Segeberger Kliniken

Address
Klosterkamp 1a, 23795 Bad Segeberg, Germany

Segeberger Kliniken - Cardiovascular Research Center

Segeberger Kliniken is a specialized cardiovascular research center with extensive expertise in the management of complex cardiac conditions, particularly focusing on atrial fibrillation and interventional cardiology. The center conducts advanced clinical trials investigating optimal anticoagulation strategies and interventional procedures for patients with cardiac arrhythmias and coronary artery disease.

  • Antithrombotic therapy optimization in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI)
  • Post-catheter ablation stroke prevention strategies for atrial fibrillation patients
  • Novel anticoagulation regimens and bleeding risk reduction in complex cardiac populations

The research program at Segeberger Kliniken emphasizes patient safety and clinical outcomes, comparing innovative monotherapy anticoagulation approaches with standard triple and dual therapy regimens. Their trials address critical questions about balancing thromboembolic protection with bleeding risk in high-risk cardiovascular patients, particularly those requiring both anticoagulation for atrial fibrillation and antiplatelet therapy following coronary stenting procedures.

Site Overview

assignment
5
connected trials
corporate_fare
5
sponsors
science
9
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
5
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
5
Active sponsors
4

Sponsor Network

Top 4 by active trials.

lock +3 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
5
Outperforms 72% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
5sponsors
Outperforms 76% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Segeberger Kliniken

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Comparison of Reduced Dual Antiplatelet Therapy with Prasugrel Monotherapy Versus Standard Regimen in STEMI Patients Undergoing OCT-Guided Versus Angiography-Guided RevascularizationResearch Maatschap Cardiologen Rotterdam ZuidPhase IIIRecruitingAug 2024

IMP list

lock Showing 1 of 9 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid3Unknown2018-01-122024-12-16

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.